Quebec
Canada
15
2024-11-28
The entities that hold a legal rights for patent applications filed by inventor Fradet Yves:
Yves Fradet from Quebec, CA has applied for patents for these inventions. The list has both pending applications and granted patents:
SURVIVIN AND MAGE-A9 DUAL-TARGETED IMMUNOTHERAPY
#2 | 2018-12-20Method to detect prostate cancer in a sample
#3 | 2018-06-21DISTINGUISHING PCA3 MESSENGER RNA SPECIES IN BENIGN AND MALIGNANT PROSTATE TISSUES
#4 | 2016-09-29Method to detect prostate cancer in a sample
#5 | 2016-07-21Distinguishing PCA3 messenger RNA species in benign and malignant prostate tissues
#6 | 2015-08-06METHODS, KITS AND COMPOSITIONS FOR PROVIDING A CLINICAL ASSESSMENT OF PROSTATE CANCER
#7 | 2014-03-27DISTINGUISHING PCA3 MESSENGER RNA SPECIES IN BENIGN AND MALIGNANT PROSTATE TISSUES
#8 | 2013-12-26METHOD TO DETECT PROSTATE CANCER IN A SAMPLE
#9 | 2013-06-13"MARKERS FOR PROSTATE CANCER PROGRESSION"
#10 | 2012-12-13Distinguishing PCA3 messenger RNA species in benign and malignant prostate tissues
#11 | 2012-12-06Method to detect prostate cancer in a sample
#12 | 2011-09-01Distinguishing PCA3 messenger RNA species in benign and malignant prostate tissues
#13 | 2010-05-27Distinguishing PCA3 messenger RNA species in benign and malignant prostate tissues
#14 | 2009-01-29Cancer Antigen Mage-A9 and Uses Thereof
#15 | 2008-10-23PCA3 messenger RNA species in benign and malignant prostate tissues
286540 ⎘